Insider trading · Q3 2026 · CIK 1385818

Aytu Biopharma, Inc (AYTU) insider trading.

In Q3 2026, insiders at Aytu Biopharma, Inc reported 8 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
8
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
8
Last filed
2026-07-30

Insiders

InsiderRelationshipTransactionsBuysSales
Donofrio John Jr.Director100
Dockery CarlDirector100
Jain AbhinavDirector100
Liu Vivian HDirector100
Selhorn Ryan JOfficer · Chief Financial Officer100
Disbrow JarrettOfficer · Chief Business Officer100
Pyszczymuka GregOfficer · Chief Commercial Officer100
Disbrow Joshua R.Director, Officer · Chief Executive Officer100

Transactions

8 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-07-28Donofrio John Jr.A (A)10,000$023,762Form 4
2026-07-28Dockery CarlA (A)10,000$031,152Form 4
2026-07-28Jain AbhinavA (A)10,000$029,500Form 4
2026-07-28Liu Vivian HA (A)10,000$029,825Form 4
2026-07-28Selhorn Ryan JA (A)25,000$074,743Form 4
2026-07-28Disbrow JarrettA (A)15,000$076,568Form 4
2026-07-28Pyszczymuka GregA (A)20,000$056,102Form 4
2026-07-28Disbrow Joshua R.A (A)30,000$0237,203Form 4

Transaction codes in this quarter

Get AYTU insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1385818&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AYTU company page · Aytu Biopharma, Inc on SEC.gov

Questions

Are insiders buying or selling Aytu Biopharma, Inc (AYTU)?

In Q3 2026, insiders at Aytu Biopharma, Inc reported 8 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Aytu Biopharma, Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/aytu.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.